Evaluating outcomes and quality of life for patients on ECMO
ESTimation of Outcome by Health-Care PRoviders Compared With TruE Outcome in Patients Undergoing Veno-arteriaL and Veno-venous ExtracorporeaL MembrAne Oxygenation
This study is trying to see how well patients do and how their quality of life is after receiving ECMO therapy for serious breathing or heart problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Heinrich-Heine University, Duesseldorf Academic / other |
| Locations | 1 site (Düsseldorf, North Rhine-Westphalia) |
| Trial ID | NCT06400797 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the outcomes and quality of life for patients undergoing extracorporeal membrane oxygenation (ECMO) therapy for severe respiratory or cardiocirculatory failure. It will compare healthcare providers' estimated outcomes with actual patient results to better understand the effectiveness of ECMO treatment. The study focuses on long-term implications of ECMO, particularly regarding quality of life after hospital discharge, which has been insufficiently studied. By gathering data on patient-centered outcomes, the research seeks to improve decision-making processes in emergency ECMO situations.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are starting ECMO therapy within 24 hours and can provide informed consent.
Not a fit: Patients under 18 years old, those who cannot communicate in the required languages, or those who have not undergone ECMO therapy will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term quality of life for ECMO patients, leading to improved treatment decisions and patient care.
How similar studies have performed: While there is limited data on long-term quality of life for ECMO patients, this study addresses a gap in existing research, making it a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age ≥ 18 years * start of ECMO therapy ≤24h * written informed consent from patient or health-care proxy Exclusion Criteria: * age \< 18 years * Language barrier (communication in German/local language or English not possible). * no ECMO therapy or ECMO therapy longer than 24h * no written consent
Where this trial is running
Düsseldorf, North Rhine-Westphalia
- University Hospital Duesseldorf — Düsseldorf, North Rhine-Westphalia, Germany (Recruiting)
Study contacts
- Principal investigator: René M'Pembele, MD — Heinrich-Heine University, Duesseldorf
- Study coordinator: René M'Pembele, MD
- Email: rene.mpembele@med.uni-duesseldorf.de
- Phone: 02118118451
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.